Shanghai Haoyuan Chemexpress Co. Ltd. A

688131 · SHG · Healthcare / Drug Manufacturers - Specialty & Generic

93.00CNY-2.54 (-2.66%)

Price History

Full chart

Market Stats

Previous Close95.54

Open95.12

Day Range92.77 – 95.91

52-Week Range59.52 – 111.30

Volume3.41M

Market Cap21.21B

P/E (TTM)81.53

Forward P/E0.00

EPS1.22

Dividend Yield0.24%

Beta0.61

50-Day Avg90.98

200-Day Avg79.17

About

Shanghai Haoyuan Chemexpress Co., Ltd. engages in the research, development, and manufacture of pharmaceutical intermediates and small molecule drugs. It offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Baofu Zheng
Employees4.54K
HeadquartersNo. 3 Building, Shanghai, China, 201203, China
Websitehttps://www.chemexpress.cn

Leadership

Mr. Baofu ZhengChairman & GM · b. 1979
Ms. Min LiCFO & Accounting Supervisor · b. 1981
Mr. Qiang GaoDeputy GM & Director · b. 1973
Ms. Ying XuHead of Analyst & Director · b. 1985
Ms. Weihong ShenBoard Secretary · b. 1986
Mr. Zhiguo ZhouCore Technical Staff · b. 1978
Mr. Kuei MeiCore Technical Staff · b. 1981

Financials

Income Statement

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	58.62M	67.09M	91.93M	117.08M	173.97M	300.20M	408.97M	635.10M	969.23M	1.36B	1.88B	2.27B	2.87B
Growth (%)	-	+14.44%	+37.03%	+27.35%	+48.59%	+72.56%	+36.23%	+55.29%	+52.61%	+40.12%	+38.44%	+20.75%	+26.35%
Cost of Revenue	44.84M	49.12M	63.53M	61.28M	83.31M	155.94M	186.52M	305.71M	473.74M	702.20M	1.11B	1.31B	1.52B
Gross Profit	13.78M	17.96M	28.41M	55.80M	90.65M	144.25M	222.44M	329.39M	495.49M	655.85M	766.71M	959.67M	2.87B
Gross Margin	23.51%	26.78%	30.90%	47.66%	52.11%	48.05%	54.39%	51.86%	51.12%	48.29%	40.78%	42.27%	100.00%
Operating Expense	11.84M	16.42M	20.76M	38.61M	74.48M	120.29M	138.06M	180.70M	285.74M	459.28M	638.39M	722.85M	2.56B
Operating Income	1.95M	1.54M	7.64M	17.20M	16.17M	23.96M	84.38M	148.69M	209.75M	196.57M	128.33M	236.82M	310.12M
Operating Margin	3.32%	2.30%	8.31%	14.69%	9.30%	7.98%	20.63%	23.41%	21.64%	14.47%	6.83%	10.43%	10.81%
EBITDA	3.03M	3.71M	10.51M	21.93M	19.26M	30.48M	92.22M	160.76M	237.82M	254.64M	250.23M	406.52M	407.87M
EBITDA Margin	5.17%	5.53%	11.43%	18.73%	11.07%	10.15%	22.55%	25.31%	24.54%	18.75%	13.31%	17.91%	14.22%
Net Income	2.32M	3.15M	8.54M	18.02M	15.01M	18.41M	73.43M	128.43M	190.98M	193.64M	127.45M	201.59M	247.77M
Net Income Margin	3.96%	4.70%	9.28%	15.39%	8.63%	6.13%	17.95%	20.22%	19.70%	14.26%	6.78%	8.88%	8.64%
R&D	-	-	-	-	28.19M	35.42M	53.04M	64.80M	103.45M	201.58M	224.12M	226.93M	237.62M
R&D as % of Total Revenue	-	-	-	-	16.21%	11.80%	12.97%	10.20%	10.67%	14.84%	11.92%	10.00%	8.28%
Interest Expense	-	-	-	-	766.61K	2.43M	2.59M	4.42M	12.51M	19.60M	38.61M	49.59M	53.80M
Interest Expense % of Total Revenue	-	-	-	-	0.44%	0.81%	0.63%	0.70%	1.29%	1.44%	2.05%	2.18%	1.88%

Balance Sheet

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	34.49M	57.39M	74.46M	156.19M	191.68M	304.48M	542.49M	856.84M	2.38B	3.60B	4.19B	5.50B	6.29B
Total Liabilities	24.80M	24.28M	41.80M	99.34M	76.94M	126.82M	142.75M	329.03M	548.11M	1.27B	1.67B	2.60B	-3.13B
Total Equity	9.70M	33.10M	32.65M	55.98M	114.74M	177.65M	399.73M	527.81M	1.82B	2.32B	2.51B	2.88B	3.13B
Cash	3.24M	17.36M	18.70M	53.01M	49.75M	79.99M	202.83M	292.03M	1.04B	460.14M	483.61M	879.55M	1.53B
Total Debt	4.00M	4.36M	11.00M	20.00M	20.00M	38.20M	24.00M	76.90M	196.66M	645.95M	953.16M	1.79B	-
Net Debt	756.23K	-13.00M	-7.70M	-33.01M	-29.75M	-41.79M	-178.83M	-215.12M	-840.52M	185.81M	469.55M	906.49M	267.93M

Cash Flow

Currency: CNY	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	1.19M	-3.96M	1.82M	-12.19M	10.63M	28.43M	57.07M	116.79M	57.83M	-240.23M	-62.27M	381.96M	317.75M
Investing Cash Flow	-2.16M	-1.60M	-3.67M	-1.41M	-12.82M	-36.47M	-70.47M	-74.16M	-305.84M	-713.00M	-279.85M	-783.65M	-
Financing Cash Flow	2.19M	19.66M	3.14M	47.70M	-766.61K	36.16M	131.16M	50.28M	1.01B	360.32M	409.21M	791.48M	-
Capital Expenditure	3.36M	1.60M	3.73M	1.41M	9.37M	35.43M	20.57M	71.16M	287.69M	581.36M	259.77M	304.46M	221.79M
Free Cash Flow	-2.17M	-5.56M	-1.91M	-13.61M	1.26M	-7.00M	36.50M	45.63M	-229.85M	-821.59M	-323.37M	77.50M	95.96M
Dividends Paid	810.46K	340.52K	3.86M	6.70M	766.61K	3.04M	24.64M	2.63M	1.82M	47.08M	40.77M	47.04M	78.02M
FCF to OCF	-182.52%	140.40%	-104.76%	111.59%	11.84%	-24.63%	63.96%	39.07%	-397.43%	342.00%	519.35%	20.29%	30.20%
Dividend Paid to FCF	-37.32%	-6.12%	-202.38%	-49.24%	60.93%	-43.45%	67.50%	5.76%	-0.79%	-5.73%	-12.61%	60.70%	81.31%

Earnings

Report Date	Aug 25, 2021	Oct 26, 2021	Apr 26, 2022	Aug 25, 2022	Oct 27, 2022	Feb 26, 2023	Apr 27, 2023
EPS Estimate	-	-	-	-	-	-	-
EPS Actual	0.39	0.93	0.59	0.52	0.40	0.34	0.43
Surprise	-	-	-	-	-	-	-
Timing	After-hours	Pre-market	After-hours	After-hours	Pre-market	After-hours	Pre-market

Key Statistics & Ratios

Market Cap21.21B

Enterprise Value24.32B

Trailing P/E81.53

Forward P/E0.00

Price / Sales6.60

Price / Book7.10

EPS1.22

Book Value15.54

Revenue (TTM)3.21B

Gross Profit (TTM)1.41B

EBITDA533.66M

Profit Margin8.07%

Operating Margin11.52%

Return on Equity7.66%

Return on Assets4.10%

Shares Outstanding213.23M

Shares Float118.38M

Beta0.61

Dividend Yield0.24%

Dividend Rate0.24

Payout Ratio6.56%

Dividends

20262×

0.09Sep 21, 20260.15Jul 13, 2026

20252×

0.08Oct 22, 20250.15May 14, 2025

20242×

0.04Oct 25, 20240.11Jun 27, 2024

20231×

0.19May 30, 2023

20221×

0.19Jun 13, 2022

Stock Splits

Jun 27, 20241.4:1
May 30, 20231.4:1
Jun 13, 20221.4:1